[The efficacy of cytoflavin used for the correction of psychoemotional and neuroimmune disturbances in the patients presenting with eczema].
Eczema is a commonest dermatological disease considered as classical psychosomatic cutaneous pathology with a neurological component. A total of 70 patients with different forms of eczema were studied to estimate the effect of standard therapy on neuroimmunological laboratory characteristics, quality of life, psychoemotional status, clinical picture and its dynamics. The results were compared with the effects of cytoflavine, a substrate antihypoxant with antioxidative and neurotropic properties. Standard treatment did not eliminate psychoemotional and neuroimmune disturbances associated with eczema. Cytoflavine therapy yielded positive clinical and laboratory results giving reason to recommend this approach for the management of eczema in clinical practice.
D I
DI
Laseev
O V
OV
Dikova
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D004485:Eczema / Q000188:drug therapy* / Q000276:immunology / Q000523:psychology; D005260:Female; D005486:Flavin Mononucleotide / Q000627:therapeutic use*; D006801:Humans; D007290:Inosine Diphosphate / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000627:therapeutic use*; D013386:Succinates / Q000627:therapeutic use*; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D013386:Succinates; C507879:cytoflavin; D009536:Niacinamide; D005486:Flavin Mononucleotide; D007290:Inosine Diphosphate